Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/16/2010US20100317586 Method for topical treatment of eye disease and composition and device for said treatment
12/16/2010US20100317585 Long-acting coagulation factors and methods of producing same
12/16/2010US20100317584 Pharmaceutical composition, package and method for rapidly reducing the uric acid in blood
12/16/2010US20100317583 Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
12/16/2010US20100317582 Novel cyclic hydrocarbon compounds for the treatment of diseases
12/16/2010US20100317581 Ipamorelin Diacetate Injection and Infusion Solutions
12/16/2010US20100317580 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
12/16/2010US20100317579 Controlled release formulations of octreotide
12/16/2010US20100317578 Method of protecting against stroke through the use of a delta opioid peptide
12/16/2010US20100317577 Methods and Compositions for Inhibiting Cell Death or Enhacing Cell Proliferation
12/16/2010US20100317576 Methods of enhancing diabetes resolution
12/16/2010US20100317575 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative
12/16/2010US20100317574 Diketopiperazine Microparticles with Defined Isomer Contents
12/16/2010US20100317573 Pediatric fiber mixture
12/16/2010US20100317572 Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound
12/16/2010US20100317571 Methods for reducing cd36 expression
12/16/2010US20100317570 Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor
12/16/2010US20100317568 Anti-Viral Compounds
12/16/2010US20100317567 Diagnosing and protecting horses against papillomavirus
12/16/2010US20100317566 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/16/2010US20100317565 Novel Peptides and Their Use for the Treatment of Edema
12/16/2010US20100317564 Immunoregulatory peptides and methods of use
12/16/2010US20100317563 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells
12/16/2010US20100317562 Dietary Compositions
12/16/2010US20100317519 Mixtures and methods for the induction of resistance in plants
12/16/2010US20100317109 Factor
12/16/2010US20100317025 Diagnostic Method for Celiac Sprue
12/16/2010US20100317011 Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
12/16/2010US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9
12/16/2010US20100316723 Compositions and methods for treating inflammation
12/16/2010US20100316717 Injectable hydrogel microspheres from aqueous two-phase system
12/16/2010US20100316714 Methods of treating disease with random copolymers
12/16/2010US20100316707 Methods and compositions for enhancing delivery of double-stranded rna or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
12/16/2010US20100316705 System for exsanguinous metabolic support of an organ or tissue
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316702 Compositions and methods for regulating erythropoeitin expression and ameliorating anemia and stimulating erythropoiesis
12/16/2010US20100316701 Compositions and method for manipulating pim-1 activity in circulatory system cells
12/16/2010US20100316700 Systemic administration of liposomal reduced glutathione for the decorporation of radioactive materials and non-radioactive mercury
12/16/2010US20100316699 Compositions and Methods for Inhibiting Viral Replication
12/16/2010US20100316698 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/16/2010US20100316697 Methods and compositions for drug targeting
12/16/2010US20100316655 Compounds with mdr1-inverse activity
12/16/2010US20100316652 Vascular endothelial cell growth factor antagonists
12/16/2010US20100316648 Novel plasminogen receptor, polypeptides and antibodies thereof
12/16/2010US20100316644 Truncated actriib-fc fusion proteins
12/16/2010US20100316643 Targeted antimicrobial moieties
12/16/2010US20100316640 Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
12/16/2010US20100316629 Use of gene expression profiling to predict survival in cancer patient
12/16/2010US20100316628 Agents and methods for treating respiratory disorders
12/16/2010US20100316626 Methods for treatment and diagnosis of psychiatric disorders
12/16/2010US20100316625 Stabilized factor ix formulations containing trehalose
12/16/2010US20100316624 Treatment of fibroses and liver disorders
12/16/2010US20100316623 Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
12/16/2010US20100316622 Diagnosis and treatment of cardiac disorders
12/16/2010US20100316621 Prophylatic agent for autoimmune disease
12/16/2010US20100316616 Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases
12/16/2010US20100316615 Antisense Oligonucleotides Against VR1
12/16/2010US20100316612 Primed cell therapy
12/16/2010US20100316610 Mutant having uracil phosphoribosyl transferase activity
12/16/2010US20100316607 Hepatitis c virus inhibitors
12/16/2010US20100316606 Stabilized formulations of peptides and proteins
12/16/2010US20100316605 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010US20100316604 Interferon lambda fusion polypeptides
12/16/2010US20100316603 Combination Immunogene Therapy
12/16/2010US20100316602 Compositions and methods for treatment of angiogenesis in pathological lesions
12/16/2010US20100316601 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
12/16/2010US20100316600 Methods of treating cancer using il-21
12/16/2010US20100316599 Methods of treating cancer using il-21
12/16/2010US20100316598 Methods of treating cancer using il-21
12/16/2010US20100316597 Methods of treating cancer using il-21
12/16/2010US20100316596 Compositions and methods for treatment of diseases and disorders associated with cytokine signaling
12/16/2010US20100316595 Methods for treating renal cell carcinoma
12/16/2010US20100316594 Modified 2' and 3' nucleoside prodrugs for treating flaviviridae infections
12/16/2010US20100316593 Pharmaceutical Formulations
12/16/2010US20100316592 AQUEOUS PREPARATION COMPRISING eMIP AS ACTIVE INGREDIENT
12/16/2010US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy
12/16/2010US20100316571 Method and Compositions for Polymer Nanocarriers Containing Therapeutic Molecules
12/16/2010US20100316569 Novel peptides
12/16/2010CA2847910A1 Anti-viral compounds
12/16/2010CA2785350A1 Il-17 for use in treating local infections in mammals
12/16/2010CA2768246A1 Serine rich peptides having antioxidative stress properties
12/16/2010CA2765233A1 Ipamorelin diacetate injection and infusion solutions
12/16/2010CA2765180A1 Novel applications of hip/pap or derivatives thereof
12/16/2010CA2765171A1 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
12/16/2010CA2765169A1 Model systems and treatment regimes for treatment of neurological disease
12/16/2010CA2765156A1 Diketopiperazine microparticles with defined isomer contents
12/16/2010CA2765099A1 Immunological targeting of pathological tau proteins
12/16/2010CA2764890A1 Methods for increasing thermogenic adipocytes
12/16/2010CA2764872A1 Hemoglobin compositions
12/16/2010CA2764797A1 Melanocortin receptor-specific peptides
12/16/2010CA2764777A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
12/16/2010CA2764759A1 Administration of interferon for prophylaxis against or treatment of pathogenic infection
12/16/2010CA2764638A1 Treatment of coagulopathy with hyperfibrinolysis
12/16/2010CA2764571A1 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
12/16/2010CA2764562A1 Vaccine therapy for choroidal neovascularization
12/16/2010CA2764505A1 Diketopiperazine microparticles with defined specific surface areas
12/16/2010CA2764385A1 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
12/16/2010CA2764189A1 Use of lcat for treating anemia and red blood cell dysfunction
12/16/2010CA2764108A1 Glucose-regulating polypeptides and methods of making and using same
12/16/2010CA2764105A1 Growth hormone polypeptides and methods of making and using same
1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 3163